In Vitro Antimicrobial Activity of Taurolidine against Isolates Associated with Catheter-Related Bloodstream Infections
Background: Taurolidine exhibits broad antimicrobial activity and is a component of a recently FDA approved catheter lock solution (DefenCath®, taurolidine 13,500 μg/mL and heparin 1000 Units/mL) indicated for reducing the risk of catheter-related bloodstream infections (CRBSI) in adult patients rec...
Saved in:
Main Authors: | Jared Crandon (Author), S.J. Ryan Arends (Author), Paul Rhomberg (Author), Mariana Castanheira (Author) |
---|---|
Format: | Book |
Published: |
Cambridge University Press,
2024-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Effectiveness of Taurolidine Antimicrobial Locks in Preventing Catheter-Related Bloodstream Infections (CRBSIs) in Children Receiving Parenteral Nutrition: A Case Series
by: Galina Ling, et al.
Published: (2024) -
Antifungal activity of Taurolidine against Mucorales: An in vitro study on clinical isolates
by: Hadis Jafarian, et al.
Published: (2022) -
Impacts of Hospital Acquired Bloodstream Infections in Patients Undergoing Hemodialysis Through a Central Venous Catheter
by: Mary Michaud, et al.
Published: (2024) -
Complications of total implantable access ports and efficacy of Taurolidine-citrate lock solution against catheter-related infections
by: Emine Ince, et al.
Published: (2014) -
Efficacy of Antimicrobial-Impregnated Catheters for Prevention of Bloodstream Infections in Pediatric Patients: A Meta-Analysis
by: Li Lai, et al.
Published: (2021)